First Rounders

First Rounder: Colin Goddard


Listen Later

Colin Goddard is former CEO of OSI Pharmaceuticals, and current chairman and CEO of Coferon. His conversation with Nature Biotechnology details the history behind OSI's blockbuster drug Tarceva (erlotinib), the benefits of having a British accent in the United States and how to survive a hostile takeover.

Hosted on Acast. See acast.com/privacy for more information.

...more
View all episodesView all episodes
Download on the App Store

First RoundersBy Nature Biotechnology

  • 4.4
  • 4.4
  • 4.4
  • 4.4
  • 4.4

4.4

63 ratings